SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-036739
Filing Date
2019-10-10
Accepted
2019-10-10 06:51:32
Documents
19
Period of Report
2019-10-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K_AMENDED AND RESTATED LICENSE AGREEMENT AND AMENDED LOAN AGREEMENT reta-8k_20191009.htm   iXBRL 8-K 52646
2 EX-10.1 reta-ex101_174.htm EX-10.1 829413
3 EX-10.2 reta-ex102_173.htm EX-10.2 120614
4 EX-99.1_PR reta-ex991_6.htm EX-99.1 15892
5 GRAPHIC gontxrcr00lo000001.jpg GRAPHIC 4533
6 GRAPHIC gontxrcr00lo000002.jpg GRAPHIC 7269
7 GRAPHIC gj3x3tzumohd000001.jpg GRAPHIC 6766
8 GRAPHIC gontxrcr00lo000003.jpg GRAPHIC 233967
  Complete submission text file 0001564590-19-036739.txt   1596508

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA reta-20191009.xsd EX-101.SCH 5964
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20191009_lab.xml EX-101.LAB 20242
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20191009_pre.xml EX-101.PRE 12081
16 EXTRACTED XBRL INSTANCE DOCUMENT reta-8k_20191009_htm.xml XML 3690
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37785 | Film No.: 191145306
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences